Post-Meeting Evaluation Instructions
- Post-Meeting Evaluation Emails will be sent:
- March 15 for sessions viewed Live or On-Demand February 25 – 27
- April 15 for sessions viewed On-Demand in Meeting Platform February 27 – March 27
- When email is received, log into the SNMMI Learning Center
- Click on “My Activities in Progress” and select “SNMMI 2022 Mid-Winter/ACNM Annual Meeting”
- Complete the Evaluation Surveys and download/print/save your CE Certificate
The 2022 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter and American College of Nuclear Medicine (ACNM) Annual Meeting provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest technologies and research in the field.
The meeting provides an in-depth review of advances in cardiovascular imaging, including imaging-guided management of CAD; blood flow quantitation with SPECT; new cardiac radiotracers and instrumentation; software/AI for cardiac SPECT and PET; cardiac hybrid imaging; radionuclide imaging of cardiac sarcoidosis and cardiac amyloidosis; myocardial blood flow; cardiac infection imaging
The meeting also covers topics on 18F FDOPA applications; Theranostics in prostate and neuroendocrine tumors; fibroblast activation protein PET; estrogen receptor targeted PET with 18F-fluoroestradiol; Y-90 therapy for metastatic thyroid cancer; infection/inflammation imaging; image quantification and associated AI applications; amyloid imaging; initiating an I-131 MIBG therapy program; implementing newly FDA approved PET/CT imaging agents.
Earning CE is as easy as 1-2-3:
- View an entire CE session at anytime.
- Click on the required non-graded pop-up questions.
- Complete the Post-Meeting Evaluation sent after the meeting.
- Examine and evaluate future directions in nuclear medicine, molecular imaging and cardiovascular imaging from a research and clinical perspective.
- Review standard, new, and relevant advances in molecular imaging including applications in neurology, cardiology, and oncology.
- Discuss new therapeutic and diagnostic agents that are impacting the practice of nuclear medicine and molecular imaging.
- Examine important regulatory information, procedures, and guidelines for imaging.
- Describe the latest indications and applications of hybrid imaging and its impact on patient management.
Click here for CE Session details, including the ABNM MOC Part II SAM sessions and the CA Scope credit categories.
CME Accreditation - AMA PRA Credits
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SNMMI designates this enduring material for a maximum of 48.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. To receive CE credit, learners must complete the online evaluation available after the program.
ABNM MOC Part II Self-Assessment Module (SAM) Credits
In addition to CME credits, physician attendees will have the opportunity to earn ABNM MOC Part II SAM credits for selected sessions. SAM credit information is listed in each session's details. In order to receive CE credit, physicians must complete the online evaluation available after the program.
VOICE Credit Statement
The Society of Nuclear Medicine and Molecular Imaging Technologist Section (SNMMI-TS), through its Verification of Involvement in Continuing Education (VOICE) program, has approved this meeting for a maximum of 48.5 continuing education hours (CEHs) of Category A+ Credit. VOICE-approved credit is recognized by most licensure states and by the NMTCB and ARRT as Category A+ credit. California Scope credit information is listed in each session's details. In order to receive CE credit, technologists must complete the online evaluation available after the program.
Pharmacy Accreditation Statement
The Society for Nuclear Medicine and Molecular Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Total available credit for pharmacists is 48.5 hours or 0.485 CEUs. Sessions within this activity have been designated as knowledge-based and application-based CPE for Pharmacists.
Session UANs start with 0210-0000-22-001-L04-P and end with 0210-0000-22-033-L04-P. Topic designations and descriptions are: L01=Disease State Management/Drug Therapy; L04=General Pharmacy Topics. Universal Activity Number (UAN) information is listed in each session's details. Release Date: February 25, 2022. Expiration Date: February 27, 2022.
In order to receive CE credit, pharmacists must complete the online evaluation available after the program. Approximately 3 weeks post-program you will receive an email with instructions to the online evaluation. Once the evaluation is complete, credit details will be uploaded to the National Association of Boards of Pharmacy (NABP) via the CPE Monitor. (Pharmacists must include their NABP eProfile ID, which can be obtained at www.MyCPEmonitor.net.)
Nuclear Physicists and Scientists: CAMPEP Credit
The SNMMI is applying for approval to grant Medical Physics Continuing Education Credit (MPCEC) through the Commission on the Accreditation of Medical Physics Programs (CAMPEP) in this educational activity. To receive CE credit, learners must complete the online evaluation available after the program. Total available credit for physicists is 48.5 MPCEC hours; approval is pending at this time.